Literature DB >> 30511426

Aerobic exercise reduces triglycerides by targeting apolipoprotein C3 in patients with coronary heart disease.

Yating Wang1, Li Shen1, Danyan Xu1.   

Abstract

BACKGROUND: Aerobic exercise, which has been shown to have beneficial effects on plasma lipids, has been recommended as an effective measure to improve the prognosis of individuals with coronary heart disease (CHD). Apolipoprotein C3 (apoC3) is associated with hypertriglyceridemia and is therefore closely related to CHD. HYPOTHESIS: We measured apoC3 concentration change in patients with CHD before and after long-term aerobic exercise.
METHODS: Thirty-eight patients with coronary heart disease were randomly assigned to a non-exercise group (19 patients) or exercise group (19 patients). Both groups received essential drugs for CHD. The non-exercise group was kept sedentary while the exercise group performed moderate-intensive aerobic exercise for 8 weeks. Lipid levels and apoC3 levels were measured on the first day and 8 weeks later.
RESULTS: Exercise for 8 weeks led to a significant decrease in concentration of triglyceride and apoC3 compared with the baseline. Triglyceride concentration changes were positively associated with apoC3 level changes.
CONCLUSIONS: Aerobic exercise can improve the lipid profile. It is effective in decreasing triglycerides by targeting apoC3 levels in patients with coronary heart disease.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  aerobic exercise; apolipoprotein C3; atherosclerotic cardiovascular disease; coronary heart disease; triglyceride

Mesh:

Substances:

Year:  2018        PMID: 30511426      PMCID: PMC6436502          DOI: 10.1002/clc.23104

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  17 in total

1.  Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.

Authors:  Michael Miller; Neil J Stone; Christie Ballantyne; Vera Bittner; Michael H Criqui; Henry N Ginsberg; Anne Carol Goldberg; William James Howard; Marc S Jacobson; Penny M Kris-Etherton; Terry A Lennie; Moshe Levi; Theodore Mazzone; Subramanian Pennathur
Journal:  Circulation       Date:  2011-04-18       Impact factor: 29.690

2.  Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.

Authors:  Anne C Goldberg; Paul N Hopkins; Peter P Toth; Christie M Ballantyne; Daniel J Rader; Jennifer G Robinson; Stephen R Daniels; Samuel S Gidding; Sarah D de Ferranti; Matthew K Ito; Mary P McGowan; Patrick M Moriarty; William C Cromwell; Joyce L Ross; Paul E Ziajka
Journal:  J Clin Lipidol       Date:  2011-04-12       Impact factor: 4.766

3.  Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins.

Authors:  Robert J Brown; William R Lagor; Sandhya Sankaranaravanan; Tomoyuki Yasuda; Thomas Quertermous; George H Rothblat; Daniel J Rader
Journal:  Circ Res       Date:  2010-06-17       Impact factor: 17.367

4.  Major lipids, apolipoproteins, and risk of vascular disease.

Authors:  Emanuele Di Angelantonio; Nadeem Sarwar; Philip Perry; Stephen Kaptoge; Kausik K Ray; Alexander Thompson; Angela M Wood; Sarah Lewington; Naveed Sattar; Chris J Packard; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-11-11       Impact factor: 56.272

5.  Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.

Authors:  Michael Miller; Christopher P Cannon; Sabina A Murphy; Jie Qin; Kausik K Ray; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2008-02-19       Impact factor: 24.094

6.  Loss-of-function mutations in APOC3, triglycerides, and coronary disease.

Authors:  Jacy Crosby; Gina M Peloso; Paul L Auer; David R Crosslin; Nathan O Stitziel; Leslie A Lange; Yingchang Lu; Zheng-zheng Tang; He Zhang; George Hindy; Nicholas Masca; Kathleen Stirrups; Stavroula Kanoni; Ron Do; Goo Jun; Youna Hu; Hyun Min Kang; Chenyi Xue; Anuj Goel; Martin Farrall; Stefano Duga; Pier Angelica Merlini; Rosanna Asselta; Domenico Girelli; Oliviero Olivieri; Nicola Martinelli; Wu Yin; Dermot Reilly; Elizabeth Speliotes; Caroline S Fox; Kristian Hveem; Oddgeir L Holmen; Majid Nikpay; Deborah N Farlow; Themistocles L Assimes; Nora Franceschini; Jennifer Robinson; Kari E North; Lisa W Martin; Mark DePristo; Namrata Gupta; Stefan A Escher; Jan-Håkan Jansson; Natalie Van Zuydam; Colin N A Palmer; Nicholas Wareham; Werner Koch; Thomas Meitinger; Annette Peters; Wolfgang Lieb; Raimund Erbel; Inke R Konig; Jochen Kruppa; Franziska Degenhardt; Omri Gottesman; Erwin P Bottinger; Christopher J O'Donnell; Bruce M Psaty; Christie M Ballantyne; Goncalo Abecasis; Jose M Ordovas; Olle Melander; Hugh Watkins; Marju Orho-Melander; Diego Ardissino; Ruth J F Loos; Ruth McPherson; Cristen J Willer; Jeanette Erdmann; Alistair S Hall; Nilesh J Samani; Panos Deloukas; Heribert Schunkert; James G Wilson; Charles Kooperberg; Stephen S Rich; Russell P Tracy; Dan-Yu Lin; David Altshuler; Stacey Gabriel; Deborah A Nickerson; Gail P Jarvik; L Adrienne Cupples; Alex P Reiner; Eric Boerwinkle; Sekar Kathiresan
Journal:  N Engl J Med       Date:  2014-06-18       Impact factor: 91.245

7.  Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study.

Authors:  Peter F Kokkinos; Charles Faselis; Jonathan Myers; Demosthenes Panagiotakos; Michael Doumas
Journal:  Lancet       Date:  2012-11-28       Impact factor: 79.321

8.  Nonfasting triglycerides and risk of ischemic stroke in the general population.

Authors:  Jacob J Freiberg; Anne Tybjaerg-Hansen; Jan Skov Jensen; Børge G Nordestgaard
Journal:  JAMA       Date:  2008-11-12       Impact factor: 56.272

9.  Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.

Authors:  Nadeem Sarwar; John Danesh; Gudny Eiriksdottir; Gunnar Sigurdsson; Nick Wareham; Sheila Bingham; S Matthijs Boekholdt; Kay-Tee Khaw; Vilmundur Gudnason
Journal:  Circulation       Date:  2006-12-26       Impact factor: 29.690

Review 10.  Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.

Authors:  M John Chapman; Henry N Ginsberg; Pierre Amarenco; Felicita Andreotti; Jan Borén; Alberico L Catapano; Olivier S Descamps; Edward Fisher; Petri T Kovanen; Jan Albert Kuivenhoven; Philippe Lesnik; Luis Masana; Børge G Nordestgaard; Kausik K Ray; Zeljko Reiner; Marja-Riitta Taskinen; Lale Tokgözoglu; Anne Tybjærg-Hansen; Gerald F Watts
Journal:  Eur Heart J       Date:  2011-04-29       Impact factor: 29.983

View more
  5 in total

Review 1.  ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.

Authors:  Ioannis Akoumianakis; Evangelia Zvintzou; Kyriakos Kypreos; Theodosios D Filippatos
Journal:  Curr Atheroscler Rep       Date:  2021-03-10       Impact factor: 5.113

2.  Serum apolipoprotein C3 levels are negatively associated with hepatitis B virus DNA in HBeAg-negative chronic hepatitis B patients.

Authors:  Yu Cui; Xiang-Dan Cui; Meng Xu; Min Fang; Mei-Juan Cai
Journal:  Lipids Health Dis       Date:  2019-06-11       Impact factor: 3.876

Review 3.  Cardiovascular Drugs and Osteoarthritis: Effects of Targeting Ion Channels.

Authors:  Raminta Vaiciuleviciute; Daiva Bironaite; Ilona Uzieliene; Ali Mobasheri; Eiva Bernotiene
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

4.  Application Value of Health Education Combined with Aerobic Exercise in Nursing of Patients with Mastitis Found in Physical Examination.

Authors:  Xiuxia Wang; Xianglian Sun
Journal:  Comput Intell Neurosci       Date:  2022-03-29

5.  The effects of exercise training on lipid profile in patients with sarcoidosis.

Authors:  Dariusz Jastrzebski; Beata Toczylowska; Elzbieta Zieminska; Aleksandra Zebrowska; Sabina Kostorz-Nosal; Elzbieta Swietochowska; Camillo Di Giulio; Dariusz Ziora
Journal:  Sci Rep       Date:  2021-03-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.